Menu
Platform
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
Blog
Case Studies
Education
CME
News
Events
About
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Platform
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
Blog
Case Studies
Education
CME
News
Events
About
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
SCHEDULE A DEMO
Home
Resources
Education
MTB Discussion for Patients with KIT and CDK12 Mutations
MTB Discussion for Patients with KIT and CDK12 Mutations
Hear experts discuss treatment options for two real-world cancer patient cases with KIT and CDK12 mutations.
Date Recorded:
December 1, 2020
Recording Length:
31 min
Topics:
ATM
,
CDK12
,
Gastric Cancer
,
KIT Exon 11
,
Prostate Cancer
,
TP53
Latest
Feb 4, 2022 | News
The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform
Read more
Jan 20, 2022 | News
OncoLens Platform Critical to Meeting the CoC’s Continuous Quality Improvement Requirements
Read more
Dec 27, 2021 | Blog
2022 Multidisciplinary Cancer Care Top Five Trends
Read more
Dec 17, 2021 | News
OncoLens Celebrates the CoC’s 100th Anniversary
Read more
